Volume 15, Number 3—March 2009
Research
Integron-mediated Multidrug Resistance in a Global Collection of Nontyphoidal Salmonella enterica Isolates
Mary G. Krauland, Jane W. Marsh, David L. Paterson, and Lee H. Harrison
Table 3
Source and ACSSuT resistance in a global collection of Salmonella enterica isolates*
| Source | Total no. isolates | No. (%) ACSSuT-resistant isolates |
|---|---|---|
| Argentina | 148 | 0 |
| Australia | 146 | 0 |
| Belgium | 66 | 0 |
| Canada | 144 | 0 |
| Denmark | 153 | 8 (5.2) |
| Germany | 150 | 1 (0.7) |
| Italy | 156 | 3 (1.9) |
| Philippines | 67 | 6 (8.9) |
| Spain | 151 | 8 (5.3) |
| South Africa | 160 | 30 (18.8) |
| Taiwan | 150 | 29 (19.3) |
| United States/ACHD | 179 | 8 (4.5) |
| United States/CDC | 150 | 1 (0.7) |
| Uganda |
100 |
10 (10.0) |
| Total | 1,920 | 104 (5.4) |
*ACSSuT, ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline; ACHD, Allegheny County Health Department; CDC, Centers for Disease Control and Prevention.
